Related references
Note: Only part of the references are listed.Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
Oliver Gross et al.
KIDNEY INTERNATIONAL (2012)
Renal Protective Effects of Aliskiren Beyond Its Antihypertensive Property in a Mouse Model of Progressive Fibrosis
Oliver Gross et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Renoprotective effects of vitamin D analogs
Yan Chun Li
KIDNEY INTERNATIONAL (2010)
Cellular Origins of Type IV Collagen Networks in Developing Glomeruli
Dale R. Abrahamson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Vitamin D levels and patient outcome in chronic kidney disease
Pietro Ravani et al.
KIDNEY INTERNATIONAL (2009)
Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome
Marie-Louise Koepke et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice
V. Ninichuk et al.
KIDNEY INTERNATIONAL (2006)
Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation
DL Andress
KIDNEY INTERNATIONAL (2006)
The podocyte's response to injury: Role in proteinuria and glomerulosclerosis
S. J. Shankland
KIDNEY INTERNATIONAL (2006)
Nephroprotection by antifibrotic and anti-inflammatory effects of the vasopeptidase inhibitor AVE7688
O Gross et al.
KIDNEY INTERNATIONAL (2005)
Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis
O Gross et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
The intrarenal renin-angiotensin system and diabetic nephropathy
RM Carey et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations
RE Gilbert et al.
DIABETIC MEDICINE (2003)
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
M Teng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome
O Gross et al.
KIDNEY INTERNATIONAL (2003)
Share Paper
